InMed Pharmaceuticals Inc
General ticker "INM" information:
- Sector: Health Care
- Industry: Pharmaceuticals
- Capitalization: $3.0B
InMed Pharmaceuticals Inc does not follow the US Stock Market performance with the rate: -25.2%.
Estimated limits based on current volatility of 5.5%: low 4.20$, high 4.69$
Factors to consider:
- Price in estimated range
- Earnings for 12 months up through Q4 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2023-06-30 to 2025-06-29
- 2023-06-30 to 2024-06-29 estimated range: [6.87$, 25.94$]
- 2024-06-29 to 2025-06-29 estimated range: [3.89$, 13.89$]
Financial Metrics affecting the INM estimates:
- Negative: Non-GAAP EPS, $ of -18.49 <= 0.10
- Negative: Operating profit margin, % of -63.40 <= 1.03
- Negative: negative Net income
- Negative: Operating cash flow per share per price, % of -10.62 <= 2.35
- Negative: Industry earnings per price (median), % of -5.82 <= 1.31
- Positive: Interest expense per share, $ of 0 <= 0
- Negative: Industry operating cash flow per share per price (median), % of -11.31 <= 3.85
Short-term INM quotes
Long-term INM plot with estimates
Financial data
| YTD | 2021-06-30 | 2022-06-30 | 2023-06-30 |
|---|---|---|---|
| Operating Revenue | $0.00MM | $1.07MM | $4.58MM |
| Operating Expenses | $10.20MM | $19.67MM | $12.51MM |
| Operating Income | $-10.20MM | $-18.60MM | $-7.93MM |
| Interest Expense | $0.36MM | $0.10MM | $0.00MM |
| R&D Expense | $5.34MM | $7.28MM | $3.73MM |
| Income(Loss) | $-10.20MM | $-18.60MM | $-7.93MM |
| Taxes | $0.00MM | $0.00MM | $0.01MM |
| Profit(Loss) | $-10.20MM | $-18.60MM | $-7.95MM |
| Stockholders Equity | $7.38MM | $9.08MM | $12.09MM |
| Assets | $9.78MM | $12.79MM | $14.11MM |
| Operating Cash Flow | $-9.79MM | $-15.58MM | $-7.28MM |
| Capital expenditure | $0.00MM | $0.04MM | $0.16MM |
| Investing Cash Flow | $-0.00MM | $-0.67MM | $-0.66MM |
| Financing Cash Flow | $10.85MM | $15.07MM | $10.68MM |
| Earnings Per Share* | $-37.78 | $-33.17 | $-3.25 |
* EPS are Split Adjusted, recent splits may be reflected with a delay.